Search Results

Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis.

• Authors : Haben, Sabrina; Ciplea, Andrea I.; Tokic, Marianne

Subjects: MULTIPLE sclerosis; EPILEPSY; PUERPERIUM

• Source: Journal of Neurology, Neurosurgery & Psychiatry; Feb2024, Vol. 95 Issue 2, p151-157, 7p

Record details

Pregnancy outcomes in patients exposed to interferon beta-1b.

• Authors : Romero, Rebecca S.¹; Lünzmann, Claudia²; Bugge, Jöerg-Peter²

Subjects: *PREGNANT women; *INTERFERON beta 1b; *TERATOGENICITY testing

• Source: Journal of Neurology, Neurosurgery & Psychiatry. May2015, Vol. 86 Issue 5, p587-589. 3p. 1 Chart.

Record details

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.

• Authors : Edan, G.¹; Kappos, L.² ; Montalbán, X.³

Subjects: *INTERFERON beta 1b; *FOLLOW-up studies (Medicine); *MULTIPLE sclerosis

• Source: Journal of Neurology, Neurosurgery & Psychiatry. Nov2014, Vol. 85 Issue 11, p1183-1189. 9p. 2 Charts, 3 Graphs.

Record details

BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.

• Authors : Fujihara, K.¹

Subjects: *INTERFERON beta 1b; *MULTIPLE sclerosis; *MEMORY loss

• Source: Journal of Neurology, Neurosurgery & Psychiatry. Nov2014, Vol. 85 Issue 11, p1179-1179. 1p.

Record details

A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients.

• Authors : Milanese C; La Mantia L; Palumbo R

Subjects: MULTIPLE sclerosis; INTERFERONS; HEALTH outcome assessment

• Source: Journal of Neurology, Neurosurgery & Psychiatry; Dec2003, Vol. 74 Issue 12, p1689-92, 4p

Record details

Why interferon beta 1b was licensed is a mystery.

• Source: BMJ: British Medical Journal (International Edition); 8/3/96, Vol. 313 Issue 7052, p297-298, 2p

Record details

Original research: Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy.

• Authors : Englund, Simon; Frisell, Thomas; Ying Qu

Subjects: SICK leave; COGNITIVE processing speed; HEMATOPOIETIC stem cell transplantation

• Source: Journal of Neurology, Neurosurgery & Psychiatry; Nov2024, Vol. 95 Issue 11, p1012-1020, 44p

Record details

Use of interferon beta 1b for multiple sclerosis. Importance of relapses must not be underestimated.

• Source: BMJ: British Medical Journal (International Edition); 11/16/96, Vol. 313 Issue 7067, p1263-1263, 1/4p

Record details

Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.

• Source: BMJ: British Medical Journal (International Edition); 11/16/96, Vol. 313 Issue 7067, p1263-1263, 1/4p

Record details

Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.

• Source: BMJ: British Medical Journal (International Edition); 11/16/96, Vol. 313 Issue 7067, p1263-1263, 1/5p

Record details